QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)

Supernus Pharmaceuticals (SUPN) News Today

$27.25
+0.31 (+1.15%)
(As of 11/30/2023 ET)
Compare
Today's Range
$26.85
▼
$27.86
50-Day Range
$22.72
▼
$29.21
52-Week Range
$21.99
▼
$42.09
Volume
251,779 shs
Average Volume
433,468 shs
Market Capitalization
$1.49 billion
P/E Ratio
66.47
Dividend Yield
N/A
Price Target
$43.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability
SourceHeadline
MarketBeat logoStockNews.com Upgrades Supernus Pharmaceuticals (NASDAQ:SUPN) to "Buy"
americanbankingnews.com - November 25 at 3:12 AM
benzinga.com logoBoard Member at Supernus Pharmaceuticals Exercises Options Worth $203K
benzinga.com - November 21 at 1:40 PM
MarketBeat logoSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Director Sells $259,150.50 in Stock
americanbankingnews.com - November 20 at 5:04 AM
finance.yahoo.com logoInsider Sell Alert: Director Frederick Hudson Sells 9,093 Shares of Supernus Pharmaceuticals ...
finance.yahoo.com - November 18 at 8:01 AM
seekingalpha.com logoSupernus Pharmaceuticals: Derisked CNS Drug Portfolio Offers Attractive Buying Opportunity
seekingalpha.com - November 10 at 5:53 PM
finance.yahoo.com logoSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 10 at 12:51 PM
markets.businessinsider.com logoPromising Progress and Potential of Qelbree Bolsters Buy Rating for Supernus Pharmaceuticals
markets.businessinsider.com - November 10 at 7:50 AM
finance.yahoo.com logoQ3 2023 Supernus Pharmaceuticals Inc Earnings Call
finance.yahoo.com - November 9 at 11:45 AM
finance.yahoo.com logoSupernus Pharmaceuticals (SUPN) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 8 at 10:45 PM
finance.yahoo.com logoSupernus (SUPN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
finance.yahoo.com - November 8 at 10:45 PM
finance.yahoo.com logoSupernus Announces Third Quarter 2023 Financial Results
finance.yahoo.com - November 8 at 5:45 PM
morningstar.com logoSupernus Pharmaceuticals Inc SUPN
morningstar.com - November 8 at 7:44 AM
finance.yahoo.com logoSupernus to Participate in the Jefferies London Healthcare Conference
finance.yahoo.com - November 7 at 9:38 PM
finance.yahoo.com logoSupernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
finance.yahoo.com - November 2 at 7:41 AM
finance.yahoo.com logoSupernus Pharmaceuticals (SUPN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
finance.yahoo.com - November 1 at 3:44 PM
finance.yahoo.com logoSupernus Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 8, 2023
finance.yahoo.com - October 25 at 8:42 PM
finance.yahoo.com logoJay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® Journey
finance.yahoo.com - October 16 at 6:12 PM
msn.com logoSupernus resubmits NDA for Parkinson's disease infusion device
msn.com - October 10 at 2:02 PM
finance.yahoo.com logoSupernus Pharmaceuticals Announces Webcast of R&D Day to be Held on October 18, 2023 in New York City
finance.yahoo.com - September 27 at 6:34 PM
finance.yahoo.com logoSupernus Pharmaceuticals (SUPN): A Hidden Gem in the Market? A Comprehensive Analysis of Its ...
finance.yahoo.com - September 26 at 7:40 PM
marketbeat.com logoTributary Capital Management LLC Lowers Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - September 24 at 8:56 AM
marketbeat.com logoPacer Advisors Inc. Makes New Investment in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - September 22 at 5:30 AM
marketbeat.com logoState Board of Administration of Florida Retirement System Sells 17,260 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - September 20 at 4:27 AM
marketbeat.com logoArmistice Capital LLC Has $157.60 Million Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - September 12 at 7:29 AM
za.investing.com logoSupernus Pharma Reports New Qelbree Data Showing Improvement in ADHD Symptoms
za.investing.com - September 10 at 6:53 PM
finance.yahoo.com logoSupernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms
finance.yahoo.com - September 9 at 10:40 PM
marketbeat.com logoSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by Bruce & Co. Inc.
marketbeat.com - September 8 at 11:16 AM
marketbeat.com logoAxiom Investors LLC DE Raises Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - September 7 at 11:27 AM
marketbeat.com logoMirabella Financial Services LLP Purchases Shares of 6,804 Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - September 6 at 9:27 AM
seekingalpha.com logoSupernus: Product Sales Stretching Higher, But Not Reflected In Economic Leverage
seekingalpha.com - September 1 at 10:07 PM
finance.yahoo.com logoSupernus to Participate in the Wells Fargo Healthcare Conference
finance.yahoo.com - August 31 at 7:14 PM
marketbeat.com logoBank of New York Mellon Corp Sells 372,890 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - August 30 at 4:34 AM
marketbeat.com logoPrincipal Financial Group Inc. Cuts Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - August 28 at 5:26 AM
marketbeat.com logoSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Bought by Connor Clark & Lunn Investment Management Ltd.
marketbeat.com - August 25 at 5:19 AM
marketbeat.com logoSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by Truist Financial Corp
marketbeat.com - August 22 at 4:30 AM
finanznachrichten.de logoSupernus Pharmaceuticals, Inc.: Bethany L. Sensenig Joins Supernus' Board of Directors
finanznachrichten.de - August 21 at 10:10 AM
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Supernus Pharmaceuticals (SUPN), Viatris (VTRS)
markets.businessinsider.com - August 21 at 10:10 AM
finance.yahoo.com logoBethany L. Sensenig Joins Supernus’ Board of Directors
finance.yahoo.com - August 21 at 10:10 AM
marketbeat.com logoNew York Life Investment Management LLC Lowers Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - August 18 at 4:52 AM
marketbeat.com logoFederated Hermes Inc. Boosts Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - August 16 at 5:23 AM
marketbeat.com logoSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Sees Large Drop in Short Interest
marketbeat.com - August 13 at 3:15 AM
finanznachrichten.de logoSupernus Pharmaceuticals, Inc.: Supernus Announces Second Quarter 2023 Financial Results
finanznachrichten.de - August 9 at 2:24 PM
finance.yahoo.com logoSupernus Pharmaceuticals (SUPN) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 8 at 11:24 PM
finance.yahoo.com logoCompared to Estimates, Supernus (SUPN) Q2 Earnings: A Look at Key Metrics
finance.yahoo.com - August 8 at 11:24 PM
finance.yahoo.com logoSupernus Announces Second Quarter 2023 Financial Results
finance.yahoo.com - August 8 at 6:23 PM
marketbeat.com logoNew York State Common Retirement Fund Sells 87,243 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - August 7 at 7:00 AM
marketbeat.com logoLisanti Capital Growth LLC Decreases Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - August 4 at 4:53 PM
marketbeat.com logoYousif Capital Management LLC Has $1.17 Million Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - August 3 at 4:48 AM
marketbeat.com logoMutual of America Capital Management LLC Sells 12,690 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
marketbeat.com - July 31 at 10:32 AM
finance.yahoo.com logo10 Best Small Cap Pharma Stocks to Buy
finance.yahoo.com - July 28 at 3:25 PM
Get Supernus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter.



SUPN Media Mentions By Week

SUPN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SUPN
News Sentiment
▼
0.93

0.75
▲
Average
Medical
News Sentiment

SUPN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SUPN Articles
This Week
▼
2

2
▲
SUPN Articles
Average Week

Get Supernus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:SUPN) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -